Urothelial carcinoma: Stem cells on the edge

Cancer and Metastasis Reviews

Volumn 28, Issue 3-4, 2009, Pages 291-304

  Brandt, William D ^a   Matsui, William ^a   Rosenberg, Jonathan E ^b   He, Xiaobing ^a   Ling, Shizhang ^a   Schaeffer, Edward M ^a   Berman, David M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bladder; Cancer stem cell; Carcinoma in situ; Differentiation; Stroma; Wnt

Indexed keywords

ABC TRANSPORTER; ABELSON KINASE; ALDEHYDE DEHYDROGENASE; BORTEZOMIB; CISPLATIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; IMATINIB; LENALIDOMIDE; PACLITAXEL; PROTEIN P53; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; SALINOMYCIN; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; BREAST CANCER; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; CYSTECTOMY; GENE MUTATION; GENE TARGETING; HUMAN; LEUKEMIA; MYELOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STROMA CELL; TREATMENT RESPONSE; UROGENITAL TRACT CANCER; UROTHELIAL CARCINOMA;

ANIMALS; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; HEMATOLOGIC NEOPLASMS; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; STROMAL CELLS; TUMOR ESCAPE; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS; UROTHELIUM; WNT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 76649107666     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-009-9187-6     Document Type: Review

References (121)

1. LL Campbell K Polyak 2007 Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6 19 2332 2338 1:CAS:528:DC%2BD2sXhtlKkt7jK 17786053 (Pubitemid 350058682)
2. PC Nowell 1976 The clonal evolution of tumor cell populations Science 194 4260 23 28 1:STN:280:DyaE283ntFWmsw%3D%3D 959840
3. X He L Marchionni DE Hansel, et al. 2009 Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma Stem Cells 27 7 1487 1495 1:CAS:528:DC%2BD1MXhtVGjsb%2FN 19544456
4. Chan, K., Espinosa, I., Chao, M., et al. (2009). Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America.
5. EA Kurzrock DK Lieu LA Degraffenried, et al. 2008 Label-retaining cells of the bladder: candidate urothelial stem cells Am J Physiol Renal Physiol 294 6 F1415 F1421 1:CAS:528:DC%2BD1cXnsVartro%3D 18367656
6. C Southam A Brunschwig 1961 Quantitative studies of autotransplantation of human cancer Cancer 14 971 978
7. IL Weissman JA Shizuru 2008 The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases Blood 112 9 3543 3553 1:CAS:528:DC%2BD1cXhtlCntr3F 18948588
8. A Bedi BA Zehnbauer MI Collector, et al. 1993 BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia Blood 81 11 2898 2902 1:STN:280:DyaK3s3ntFCktg%3D%3D 8499629
9. T Lapidot C Sirard J Vormoor, et al. 1994 A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 6464 645 648 1:STN:280:DyaK2c7ltVKrsg%3D%3D 7509044
10. D Bonnet JE Dick 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nature Medicine 3 7 730 737 1:CAS:528:DyaK2sXkt1GrtLY%3D 9212098
11. T Reya SJ Morrison MF Clarke, et al. 2001 Stem cells, cancer, and cancer stem cells Nature 414 6859 105 111 1:CAS:528:DC%2BD3MXot1ahs7c%3D 11689955
12. AV Krivtsov D Twomey Z Feng, et al. 2006 Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9 Nature 442 7104 818 822 1:CAS:528:DC%2BD28XotFKmtr0%3D 16862118
13. AV Krivtsov Z Feng SA Armstrong 2009 Transformation from committed progenitor to leukemia stem cells Annals of the New York Academy of Sciences 1176 144 149 1:CAS:528:DC%2BD1MXhtlKqt7fM 19796242
14. MF Clarke JE Dick PB Dirks, et al. 2006 Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Research 66 19 9339 9344 1:CAS:528:DC%2BD28XhtVamsr3I 16990346
15. PN Kelly A Dakic JM Adams, et al. 2007 Tumor growth need not be driven by rare cancer stem cells Science 317 5836 337 1:CAS:528:DC%2BD2sXnslGrsr0%3D 17641192
16. F Michor TP Hughes Y Iwasa, et al. 2005 Dynamics of chronic myeloid leukaemia Nature 435 7046 1267 1270 1:CAS:528:DC%2BD2MXls1Ontbo%3D 15988530
17. P le Coutre E Tassi M Varella-Garcia, et al. 2000 Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification Blood 95 5 1758 1766 10688835
18. SM Graham HG Jørgensen E Allan, et al. 2002 Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro Blood 99 1 319 325 1:CAS:528: DC%2BD38XivF2gug%3D%3D 11756187
19. W Matsui CA Huff Q Wang, et al. 2004 Characterization of clonogenic multiple myeloma cells Blood 103 6 2332 2336 1:CAS:528:DC%2BD2cXitlCjs74%3D 14630803
20. W Matsui Q Wang JP Barber, et al. 2008 Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance Cancer Research 68 1 190 197 1:CAS:528:DC%2BD1cXoslSi 18172311
21. M Al-Hajj MS Wicha A Benito-Hernandez, et al. 2003 Prospective identification of tumorigenic breast cancer cells Proceedings of the National Academy of Sciences of the United States of America 100 7 3983 3988 1:CAS:528:DC%2BD3sXivFSqtbs%3D 12629218 (Pubitemid 36418143)
22. M Shipitsin LL Campbell P Argani, et al. 2007 Molecular definition of breast tumor heterogeneity Cancer Cell 11 3 259 273 1:CAS:528: DC%2BD2sXjsVymtL0%3D 17349583
23. A Eramo F Lotti G Sette, et al. 2008 Identification and expansion of the tumorigenic lung cancer stem cell population Cell Death and Differentiation 15 3 504 514 1:CAS:528:DC%2BD1cXitVOlsLo%3D 18049477
24. P Dalerba SJ Dylla I-K Park, et al. 2007 Phenotypic characterization of human colorectal cancer stem cells Proceedings of the National Academy of Sciences of the United States of America 104 24 10158 10163 1:CAS:528: DC%2BD2sXmvVCntLw%3D 17548814
25. CA O'brien A Pollett S Gallinger, et al. 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 7123 106 110 17122772
26. L Ricci-Vitiani DG Lombardi E Pilozzi, et al. 2007 Identification and expansion of human colon-cancer-initiating cells Nature 445 7123 111 115 1:CAS:528:DC%2BD2sXhsFOmug%3D%3D 17122771
27. L Patrawala T Calhoun R Schneider-Broussard, et al. 2006 Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 12 1696 1708 1:CAS:528:DC%2BD28XitlKntbk%3D 16449977
28. AB Alvero R Chen H-H Fu, et al. 2009 Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance Cell Cycle 8 1 158 166 1:CAS:528:DC%2BD1MXlvFSqt7s%3D 19158483
29. ME Prince R Sivanandan A Kaczorowski, et al. 2007 Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proceedings of the National Academy of Sciences of the United States of America 104 3 973 978 1:CAS:528:DC%2BD2sXhtVSitLk%3D 17210912
30. E Quintana M Shackleton MS Sabel, et al. 2008 Efficient tumour formation by single human melanoma cells Nature 456 7222 593 598 1:CAS:528: DC%2BD1cXhsVGlur7K 19052619
31. JA Kennedy F Barabé AG Poeppl, et al. 2007 Comment on "Tumor growth need not be driven by rare cancer stem cells" Science 318 5857 1722 1:CAS:528:DC%2BD2sXhsVWhu7fO 18079385 Author reply
32. AA Donjacour GR Cunha 1991 Stromal regulation of epithelial function Cancer Treatment and Research 53 335 364 1:STN:280:DyaK3M7lvFWlug%3D%3D 1672086
33. I Malanchi J Huelsken 2009 Cancer stem cells: never Wnt away from the niche Current Opinion in Oncology 21 1 41 46 19125017
34. SJ Morrison AC Spradling 2008 Stem cells and niches: mechanisms that promote stem cell maintenance throughout life Cell 132 4 598 611 1:CAS:528:DC%2BD1cXivVagtrs%3D 18295578
35. NM Joseph SJ Morrison 2005 Toward an understanding of the physiological function of mammalian stem cells Dev Cell 9 2 173 183 1:CAS:528: DC%2BD2MXovFSgsro%3D 16054025
36. VC Daniel L Marchionni JS Hierman, et al. 2009 A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro Cancer Research 69 8 3364 3373 1:CAS:528: DC%2BD1MXksV2hsb8%3D 19351829
37. L Jin KJ Hope Q Zhai, et al. 2006 Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nature Medicine 12 10 1167 1174 16998484
38. AE Karnoub AB Dash AP Vo, et al. 2007 Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 7162 557 563 1:CAS:528:DC%2BD2sXhtFagt7fI 17914389
39. TD Tlsty LM Coussens 2006 Tumor stroma and regulation of cancer development Annual Review of Pathology 1 119 150 1:CAS:528:DC%2BD28XktVOitb0%3D 18039110
40. W-W Lin M Karin 2007 A cytokine-mediated link between innate immunity, inflammation, and cancer Journal of Clinical Investigation 117 5 1175 1183 1:CAS:528:DC%2BD2sXlt1Omtrk%3D 17476347
41. CR Walkley GH Olsen S Dworkin, et al. 2007 A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency Cell 129 6 1097 1110 1:CAS:528:DC%2BD2sXntVOnt74%3D 17574023
42. AF Olumi GD Grossfeld SW Hayward, et al. 1999 Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium Cancer Research 59 19 5002 5011 1:CAS:528:DyaK1MXmslWktbc%3D 10519415
43. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10647931
44. JE Visvader GJ Lindeman 2008 Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nature Reviews Cancer 8 10 755 768 1:CAS:528:DC%2BD1cXhtFCrtb3K 18784658
45. K Hochedlinger R Blelloch C Brennan, et al. 2004 Reprogramming of a melanoma genome by nuclear transplantation Genes and Development 18 15 1875 1885 1:CAS:528:DC%2BD2cXms1Ghs74%3D 15289459
46. MJ Bissell MA Labarge 2005 Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cells 7 1 17 23 1:CAS:528:DC%2BD2MXhsVaitrs%3D
47. T Farsund 1976 Kinetics of mouse urinary bladder epithelium. II. Changes in proliferation and nuclear DNA content during necrosis regeneration, and hyperplasia caused by a single dose of cyclophosphamide Virchows Arch B Cell Pathol 21 4 279 298 1:CAS:528:DyaE2sXhtFyltg%3D%3D 824809
48. SA Lewis 2000 Everything you wanted to know about the bladder epithelium but were afraid to ask Am J Physiol Renal Physiol 278 6 F867 F874 1:CAS:528:DC%2BD3cXks1ymtL0%3D 10836974
49. BF Martin 1972 Cell replacement and differentiation in transitional epithelium: a histological and autoradiographic study of the guinea-pig bladder and ureter Journal of Anatomy 112 Pt 3 433 455 1:STN:280:DyaE3s%2FkvFKjsA%3D%3D 4636798
50. CP Diggle S Cruickshank JD Olsburgh, et al. 2003 Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor American Journal of Pathology 163 2 493 504 1:CAS:528:DC%2BD3sXmslSnsL4%3D 12875970
51. HB Grossman C Lee J Bromberg, et al. 2000 Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer Oncology Reports 7 1 13 16 1:CAS:528:DC%2BD3cXjslKisw%3D%3D 10601583
52. YM Yang JW Chang 2008 Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells LCNV 26 7 725 733 1:CAS:528:DC%2BD1cXpt1ensr4%3D
53. PG Chu LM Weiss 2002 Keratin expression in human tissues and neoplasms Histopathology 40 5 403 439 1:STN:280:DC%2BD383ntFOrtA%3D%3D 12010363
54. LS Baskin SW Hayward PF Young, et al. 1996 Ontogeny of the rat bladder: smooth muscle and epithelial differentiation Acta Anatomica (Basel) 155 3 163 171 1:STN:280:DyaK2s%2FisVGmtA%3D%3D
55. XR Wu M Manabe J Yu, et al. 1990 Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation Journal of Biological Chemistry 265 31 19170 19179 1:CAS:528:DyaK3cXmtVyktrg%3D 2229070
56. J De La Rosette F Smedts C Schoots, et al. 2002 Changing patterns of keratin expression could be associated with functional maturation of the developing human bladder Journal of Urology 168 2 709 717
57. RE Buller JS Skilling AK Sood, et al. 1998 Field cancerization: why late "recurrent" ovarian cancer is not recurrent American Journal of Obstetrics and Gynecology 178 4 641 649 1:STN:280:DyaK1c3jvFShug%3D%3D 9579425
58. J Wang L Lin V Parkash, et al. 2003 Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems International Journal of Cancer 103 3 328 334 1:CAS:528:DC%2BD3sXht1yjtA%3D%3D
59. JD Woodruff CG Julian 1969 Multiple malignancy in the upper genital canal American Journal of Obstetrics and Gynecology 103 6 810 822 1:STN:280:DyaF1M7hsFSitg%3D%3D 5765964
60. C Billerey D Chopin MH Aubriot-Lorton, et al. 2001 Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors American Journal of Pathology 158 6 1955 1959 1:CAS:528:DC%2BD3MXkvFyksLg%3D 11395371
61. BWG van Rhijn R Montironi EC Zwarthoff, et al. 2002 Frequent FGFR3 mutations in urothelial papilloma Journal of Pathology 198 2 245 251 12237885
62. X-R Wu 2005 Urothelial tumorigenesis: a tale of divergent pathways Nature Reviews Cancer 5 9 713 725 1:CAS:528:DC%2BD2MXpsleksLs%3D 16110317
63. L Dyrskjøt M Kruhøffer T Thykjaer, et al. 2004 Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification Cancer Research 64 11 4040 4048 15173019
64. K Zieger L Dyrskjøt C Wiuf, et al. 2005 Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors Clinical Cancer Research 11 21 7709 7719 1:CAS:528:DC%2BD2MXhtF2is7fE 16278391
65. C Cordon-Cardo ZF Zhang G Dalbagni, et al. 1997 Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors Cancer Research 57 7 1217 1221 1:CAS:528:DyaK2sXit1Kqu74%3D 9102201
66. RJ Cote MD Dunn SJ Chatterjee, et al. 1998 Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53 Cancer Research 58 6 1090 1094 1:CAS:528:DyaK1cXhvV2ku78%3D 9515785
67. HB Grossman M Liebert M Antelo, et al. 1998 p53 and RB expression predict progression in T1 bladder cancer Clinical Cancer Research 4 4 829 834 1:CAS:528:DyaK1cXisFels7o%3D 9563875
68. ZT Zhang J Pak E Shapiro, et al. 1999 Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma Cancer Research 59 14 3512 3517 1:CAS:528:DyaK1MXks1Omsbg%3D 10416618
69. AM Puzio-Kuter M Castillo-Martin CW Kinkade, et al. 2009 Inactivation of p53 and Pten promotes invasive bladder cancer Genes and Development 23 6 675 680 1:CAS:528:DC%2BD1MXktVWltrk%3D 19261747
70. SA Burchill DE Neal J Lunec 1994 Frequency of H-ras mutations in human bladder cancer detected by direct sequencing British Journal of Urology 73 5 516 521 1:STN:280:DyaK2c3ot1GgtQ%3D%3D 8012773
71. AP Feinberg B Vogelstein MJ Droller, et al. 1983 Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer Science 220 4602 1175 1177 1:STN:280:DyaL3s3itlGmtA%3D%3D 6304875
72. L Mo X Zheng H-Y Huang, et al. 2007 Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis Journal of Clinical Investigation 117 2 314 325 1:CAS:528:DC%2BD2sXhs1Oqsbo%3D 17256055
73. HB Grossman RB Natale CM Tangen, et al. 2003 Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer New England Journal of Medicine 349 9 859 866 1:CAS:528: DC%2BD3sXmvVSnu7Y%3D 12944571
74. Collaboration ABCAM-a 2005 Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration European Urology 48 2 202 205 discussion 5-6
75. R Sylvester C Sternberg 2000 The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why Annals of Oncology 11 7 851 856 1:STN:280:DC%2BD3cvks1Sgug%3D%3D 10997813
76. Collaboration ABCAM-a (2006) Adjuvant chemotherapy for invasive bladder cancer (individual patient data). Cochrane database of systematic reviews (online) (2):CD006018
77. CN Sternberg P de Mulder JH Schornagel, et al. 2006 Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours European Journal of Cancer 42 1 50 54 1:CAS:528:DC%2BD2MXhtlCktL3I 16330205
78. H von der Maase SW Hansen JT Roberts, et al. 2000 Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study Journal of Clinical Oncology 18 17 3068 3077 11001674
79. H von der Maase L Sengelov JT Roberts, et al. 2005 Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer Journal of Clinical Oncology 23 21 4602 4608 16034041
80. PB Gupta TT Onder G Jiang, et al. 2009 Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 4 645 659 1:CAS:528:DC%2BD1MXhsVCjs73E 19682730
81. OH Yilmaz R Valdez BK Theisen, et al. 2006 Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells Nature 441 7092 475 482 1:CAS:528:DC%2BD28XkvVykurY%3D 16598206
82. V Janzen DT Scadden 2006 Stem cells: good, bad and reformable Nature 441 7092 418 419 1:CAS:528:DC%2BD28XkvVyktbg%3D 16724049
83. J Zhang JC Grindley T Yin, et al. 2006 PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention Nature 441 7092 518 522 1:CAS:528:DC%2BD28XkvVyku74%3D 16633340
84. R Liu X Wang GY Chen, et al. 2007 The prognostic role of a gene signature from tumorigenic breast-cancer cells New England Journal of Medicine 356 3 217 226 1:CAS:528:DC%2BD2sXns12mug%3D%3D 17229949
85. W Wang S Goswami K Lapidus, et al. 2004 Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors Cancer Research 64 23 8585 8594 1:CAS:528:DC%2BD2cXhtVCjs73N 15574765
86. L Dyrskjøt T Thykjaer M Kruhøffer, et al. 2003 Identifying distinct classes of bladder carcinoma using microarrays Nature Genetics 33 1 90 96 12469123
87. PJ Wild A Herr C Wissmann, et al. 2005 Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder Clinical Cancer Research 11 12 4415 4429 1:CAS:528:DC%2BD2MXltFeksrs%3D 15958626
88. K Zieger N Marcussen M Borre, et al. 2009 Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development International Journal of Cancer 125 9 2095 2103 1:CAS:528:DC%2BD1MXhtVOms7bE
89. R Nusse 2008 Wnt signaling and stem cell control Cell Res 18 5 523 527 1:CAS:528:DC%2BD1cXltlSmsL8%3D 18392048
90. S Urakami H Shiina H Enokida, et al. 2006 Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway Clinical Cancer Research 12 2 383 391 1:CAS:528:DC%2BD28XmtlKjsA%3D%3D 16428476
91. TD Bui T O'Brien J Crew, et al. 1998 High expression of Wnt7b in human superficial bladder cancer vs invasive bladder cancer British Journal of Cancer 77 2 319 324 1:STN:280:DyaK1c7itV2jsA%3D%3D 9461004
92. S Urakami H Shiina H Enokida, et al. 2006 Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection Clinical Cancer Research 12 7 Pt 1 2109 2116 1:CAS:528:DC%2BD28XjtlChsrs%3D 16609023
93. R Stoehr RC Krieg R Knuechel, et al. 2002 No evidence for involvement of beta-catenin and APC in urothelial carcinomas International Journal of Oncology 20 5 905 911 1:CAS:528:DC%2BD38XktVSmt7o%3D 11956582
94. E Kastritis S Murray F Kyriakou, et al. 2009 Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication International Journal of Cancer 124 1 103 108 1:CAS:528:DC%2BD1cXhsFahtrnO
95. R Stoehr C Wissmann H Suzuki, et al. 2004 Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer Laboratory Investigation 84 4 465 478 1:CAS:528:DC%2BD2cXmtF2itrg%3D 14968126
96. C Wissmann PJ Wild S Kaiser, et al. 2003 WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer Journal of Pathology 201 2 204 212 1:CAS:528:DC%2BD3sXovVCrtrg%3D 14517837
97. Y Tang AR Simoneau WX Liao, et al. 2009 WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells Mol Cancer Ther 8 2 458 468 1:CAS:528:DC%2BD1MXhvFamsbY%3D 19174556
98. AH Schinkel JW Jonker 2003 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Advanced Drug Delivery Reviews 55 1 3 29 1:CAS:528:DC%2BD3sXivVWnsQ%3D%3D 12535572
99. S Zhou JD Schuetz KD Bunting, et al. 2001 The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nature Medicine 7 9 1028 1034 1:CAS:528: DC%2BD3MXmvFOlsrk%3D 11533706
100. T Chiba K Kita Y-W Zheng, et al. 2006 Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties Hepatology 44 1 240 251 1:CAS:528:DC%2BD28XnsFWjur0%3D 16799977
101. N Haraguchi T Utsunomiya H Inoue, et al. 2006 Characterization of a side population of cancer cells from human gastrointestinal system Stem Cells 24 3 506 513 1:CAS:528:DC%2BD28XhtFKitbvL 16239320
102. T Kondo T Setoguchi T Taga 2004 Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line Proceedings of the National Academy of Sciences of the United States of America 101 3 781 786 1:CAS:528:DC%2BD2cXhsVWhurc%3D 14711994
103. N Mitsutake A Iwao K Nagai, et al. 2007 Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively Endocrinology 148 4 1797 1803 1:CAS:528: DC%2BD2sXjvVOhtLo%3D 17234707
104. L Patrawala T Calhoun R Schneider-Broussard, et al. 2005 Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic Cancer Research 65 14 6207 6219 1:CAS:528:DC%2BD2MXmt1egsrk%3D 16024622
105. PP Szotek R Pieretti-Vanmarcke PT Masiakos, et al. 2006 Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness Proceedings of the National Academy of Sciences of the United States of America 103 30 11154 11159 1:CAS:528: DC%2BD28XnvVamurs%3D 16849428
106. C Hirschmann-Jax AE Foster GG Wulf, et al. 2004 A distinct "side population" of cells with high drug efflux capacity in human tumor cells Proceedings of the National Academy of Sciences of the United States of America 101 39 14228 14233 1:CAS:528:DC%2BD2cXosVyltr8%3D 15381773
107. Oates, J., Grey, B., & Addla, S., et al. (2009). Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers. Stem Cells Dev.
108. Z-F Ning Y-J Huang T-X Lin, et al. 2009 Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24 Journal of International Medical Research 37 3 621 630 1:CAS:528:DC%2BD1MXhtFSqtrfO 19589244
109. SJ Dylla L Beviglia I-K Park, et al. 2008 Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy PLoS ONE 3 6 e2428 18560594
110. MB Kastan E Schlaffer JE Russo, et al. 1990 Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells Blood 75 10 1947 1950 1:CAS:528:DyaK3cXktlKkurc%3D 2337669
111. KR Weishaupt CJ Gomer TJ Dougherty 1976 Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor Cancer Research 36 7 PT 1 2326 2329 1:CAS:528:DyaE28XkslKisrw%3D 1277137
112. M Diehn RW Cho NA Lobo, et al. 2009 Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 458 7239 780 783 1:CAS:528:DC%2BD1MXhsVCrtbc%3D 19194462
113. PO Berberat Z Dambrauskas A Gulbinas, et al. 2005 Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment Clinical Cancer Research 11 10 3790 3798 1:CAS:528: DC%2BD2MXktFyruro%3D 15897578
114. L Eisele L Klein-Hitpass N Chatzimanolis, et al. 2007 Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia Acta Haematologica 117 1 8 15 1:CAS:528:DC%2BD28XhtlCht7rP 17095854
115. S Josson Y Xu F Fang, et al. 2006 RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells Oncogene 25 10 1554 1559 1:CAS:528:DC%2BD28XitFGhtro%3D 16261162
116. AD Schimmer 2004 Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice Cancer Research 64 20 7183 7190 1:CAS:528:DC%2BD2cXosFyntr8%3D 15492230
117. M Todaro MP Alea AB Di Stefano, et al. 2007 Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 Cell Stem Cell 1 4 389 402 1:CAS:528:DC%2BD2sXht1eku7fJ 18371377
118. C Conticello F Pedini A Zeuner, et al. 2004 IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins Journal of Immunology 172 9 5467 5477 1:CAS:528:DC%2BD2cXjt1Ckt70%3D
119. BB Aggarwal AB Kunnumakkara KB Harikumar, et al. 2009 Signal transducer and activator of transcription-3, inflammation, and cancer Annals of the New York Academy of Sciences 1171 1 59 76 1:CAS:528:DC%2BD1MXht1Sntb3J 19723038
120. R Majeti MP Chao AA Alizadeh, et al. 2009 CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells Cell 138 2 286 299 1:CAS:528:DC%2BD1MXhtVSgtr3N 19632179
121. DS Ritchie MJ Smyth 2009 A new therapeutic target for leukemia comes to the surface Cell 138 2 226 228 1:CAS:528:DC%2BD1MXhtVSgtrzJ 19632173